The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human trial of ONC201 in patients with refractory solid tumors.
 
Mark N. Stein
No Relationships to Disclose
 
Nancy Chan
Research Funding - Amgen; Bristol-Myers Squibb
 
Ann W. Silk
No Relationships to Disclose
 
Bruno Fang
No Relationships to Disclose
 
Howard Kaufman
Honoraria - Alkermes; Amgen; EMD Serono; Merck; Prometheus; Sanofi Pasteur
Consulting or Advisory Role - Alkermes; Amgen; Merck; Merck Serono; Prometheus
Speakers' Bureau - Merck
Research Funding - Bristol-Myers Squibb/Medarex
Travel, Accommodations, Expenses - Alkermes; EMD Serono; Sanofi
 
Bruce George Haffty
No Relationships to Disclose
 
Tracie Saunders
No Relationships to Disclose
 
Saltanat Najmi
No Relationships to Disclose
 
Ling Zheng
No Relationships to Disclose
 
Martin Stogniew
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
Patents, Royalties, Other Intellectual Property - Oncoceutics
 
Joshua E. Allen
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
Patents, Royalties, Other Intellectual Property - Oncoceutics
 
Wolfgang Oster
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
 
Joseph R. Bertino
No Relationships to Disclose
 
Janice M. Mehnert
Consulting or Advisory Role - Amgen/Dompé (Inst)
Research Funding - Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Other Relationship - Amgen